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Campylobacter contaminated poultry remains the major cause of foodborne
gastroenteritis worldwide, calling for novel antibacterials. We previously developed the
concept of Innolysin composed of an endolysin fused to a phage receptor binding
protein (RBP) and provided the proof-of-concept that Innolysins exert bactericidal
activity against Escherichia coli. Here, we have expanded the Innolysin concept to target
Campylobacter jejuni. As no C. jejuni phage RBP had been identified so far, we first
showed that the H-fiber originating from a CJIE1-like prophage of C. jejuni CAMSA2147
functions as a novel RBP. By fusing this H-fiber to phage T5 endolysin, we constructed
Innolysins targeting C. jejuni (Innolysins Cj). Innolysin Cj1 exerts antibacterial activity
against diverse C. jejuni strains after in vitro exposure for 45 min at 20◦C, reaching
up to 1.30 ± 0.21 log reduction in CAMSA2147 cell counts. Screening of a library of
Innolysins Cj composed of distinct endolysins for growth inhibition, allowed us to select
Innolysin Cj5 as an additional promising antibacterial candidate. Application of either
Innolysin Cj1 or Innolysin Cj5 on chicken skin refrigerated to 5◦C and contaminated
with C. jejuni CAMSA2147 led to 1.63 ± 0.46 and 1.18 ± 0.10 log reduction of
cells, respectively, confirming that Innolysins Cj can kill C. jejuni in situ. The receptor of
Innolysins Cj remains to be identified, however, the RBP component (H-fiber) recognizes
a novel receptor compared to lytic phages binding to capsular polysaccharide or flagella.
Identification of other unexplored Campylobacter phage RBPs may further increase the
repertoire of new Innolysins Cj targeting distinct receptors and working as antibacterials
against Campylobacter.
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INTRODUCTION
Campylobacter jejuni is the major cause of foodborne gastroenteritis worldwide, leading to more
than 245,000 human cases annually only in Europe, and is thus associated with a significant
economic burden [European Food Safety Authority (EFSA), 2015]. C. jejuni colonizes the poultry
intestine to high numbers and despite numerous efforts, sustainable solutions for controlling
this pathogen is yet not available. The use of lytic phages for specific biocontrol of C. jejuni in
primary poultry production has shown promising results, but is also hampered by phage resistance
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development (Loc Carrillo et al., 2005; Holst Sørensen et al., 2012;
Fischer et al., 2013; Hammerl et al., 2014; Richards et al., 2019).
So far, lytic phages of C. jejuni have been shown to recognize
the capsular polysaccharides or the flagella (Sørensen et al., 2015)
and application of phage cocktails targeting both receptors have
led to less than 1 log reduction in bacterial counts on chicken
skin (Zampara et al., 2017). Therefore, alternative antibacterial
agents are needed to eliminate this pathogen. One such approach
may be the design and use of phage-derived enzymes instead of
replicating phages.
Endolysins are phage-encoded enzymes that degrade
the peptidoglycan leading to osmotic imbalance and cell
lysis. Endolysins have been successfully used as alternative
antibacterials against diverse pathogenic bacteria, displaying
low probability of resistance development (Nelson et al., 2012).
However, their antibacterial activity is generally limited toward
Gram-positive bacteria, as Gram-negative bacteria possess
an outer membrane that hinders access of endolysins to the
peptidoglycan layer (Fernández-Ruiz et al., 2018; Gutiérrez
and Briers, 2021). Over the last decade, research has been
focused on developing approaches to enable endolysins to
overcome the outer membrane barrier of Gram-negative
bacteria. Fusion of endolysins with the binding domains of
bacteriocins is one of such approaches, allowing the hybrid
endolysins to overcome the outer membrane barrier, putatively
through the target outer membrane proteins (Lukacik et al.,
2012; Yan et al., 2017; Heselpoth et al., 2019). Alternatively,
endolysins fused with polycationic and amphipathic peptides
appear to interfere with the outer membrane integrity. These
artificial endolysins, known as Artilysins R©, are under commercial
development and with reported antibacterial activities against
Pseudomonas aeruginosa, Acinetobacter baumannii, and
colistin-resistant E. coli (Briers et al., 2014; Defraine et al.,
2016; Schirmeier et al., 2018). Recently, we provided a proof
of concept for the use of a phage receptor binding protein
(RBP), enabling the fused endolysin to exert antibacterial
activity and kill E. coli (Zampara et al., 2020). In our previous
work, we constructed hundreds of RBP-endolysin hybrids
(Innolysins) by fusing 24 different endolysins with Pb5
(phage T5 RBP) in different configurations. Screening of these
Innolysin variants for antibacterial activity identified Innolysin
Ec21, which was able to reduce E. coli resistant to third-
generation cephalosporins by 3.31 ± 0.53 log. The antibacterial
activity of Innolysins Ec was proved to be dependent on the
Pb5 cognate receptor, FhuA (Zampara et al., 2020). Thus,
the phage RBP provides specificity to the fused endolysin
of the Innolysin Ec. Moreover, discovery of novel phage
RBPs may allow development of Innolysins against other
Gram-negative bacteria.
The identification of Campylobacter phage RBPs is challenged
by the small number of in-depth characterized Campylobacter
phages and publicly available genomes. Although a putative
RBP (Gp047) of phage NCTC12673 was proposed and shown
to bind to acetamidino-modified pseudaminic acid residues of
the flagella, it was later reported unlikely to be an RBP, as it
could not be detected in the mature virion (Javed et al., 2015).
Thus, up to date no RBPs of lytic C. jejuni phages have been
identified. However, putative RBPs of Campylobacter prophages
may be used as a source of RBPs. The prophage elements of
C. jejuni were discovered when the genome sequence of the
chicken isolate C. jejuni RM1221 was compared to the reference
genome of C. jejuni NCTC11168 and revealed three C. jejuni
integrated elements (CJIEs) (Parkhill et al., 2000; Fouts et al.,
2005). The first element known as CMLP1 or CJIE1was shown
to be a Mu-like phage, which encodes several proteins similar
to phage Mu, including transposase homologs, as well as the
five-base (TATGC) direct repeats flanking the element (Fouts
et al., 2005; Clark and Ng, 2008). Unfortunately, isolation of
free phage particles has been repeatedly unsuccessful and so
far, it is not understood how CJIE1-like prophages recognize
their host and their RBPs have not been identified. Sequence
analysis of CJIE1-like prophages of different strains showed
several insertion and deletions (Clark and Ng, 2008; Clark,
2011) and also identified a region of 372 nucleotides with high
variation in a gene suggested to encode the tail fiber protein H
(Clark and Ng, 2008).
Here, we aimed to design Innolysins targeting Campylobacter
(Innolysin Cj) by combining the specificity of an RBP protein
with the antibacterial activity of endolysins. To do so, we first
confirmed the function of a putative RBP found in CJIE1-
like prophage in CAMSA2147 and then fused it to different
endolysins for construction of Innolysins Cj. Two of the
constructed Innolysins were able to kill C. jejuni in vitro and
in situ on artificially contaminated chicken skin. Our work
provides novel insights in designing alternative antibacterials
with targeted killing against Campylobacter.
MATERIALS AND METHODS
Bacterial Strains, Growth Conditions,
and Media
Bacterial strains used in this study are listed in Table 1 and
Table 2. C. jejuni strains were routinely grown on Blood Agar
Base II (Oxoid) supplemented with 5% calf blood (BA) at
42◦C under microaerobic conditions (6% CO2, 6% O2, 84.5%
N2, and 3.5% H2). Luria-Bertani broth (LB) and LB agar
(LA) (Difco) were used for growing E. coli, while Tryptic
Soy Broth (TSB) and Tryptic Soy Agar (TSA) were used
for P. aeruginosa. When needed 100 µg/ml of kanamycin
and 50 µg/ml of chloramphenicol were used for selection of
E. coli transformants or 15 µg/ml gentamicin for selection of
P. aeruginosa transformants.
Bioinformatic Analysis
To predict the protein function and the domains of CAMSA2147
prophage H-fiber (WP_002878910.1) and the downstream
putative chaperone (WP_002878909.1), we mined CJIE1-like
prophage sequences in our collection using CJIE1 of C. jejuni
RM1221 (NC_003917.7) as query. Blast similarity allowed
determining a CJIE1-like prophage in the genome assembly of
CAMSA2147. Then, gene syntheny was inspected manually, in
comparison to phage Mu and phage P2. Respective domains were
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TABLE 1 | Bacterial strains.
Description References
P. aeruginosa strains
PAO1 Clinical wound isolate; R2-pyocin producer Williams et al., 2008
PAO1 1prf15 P. aeruginosa PAO1 lacking the R2-pyocin tail fiber due to an in-frame deletion of codons
11–301 of prf15
Williams et al., 2008
PEG02 PAO1 1prf15/pM63, campycin + chaperone co-expression strain, Gmr (15 µg/ml) This study
PEG16 PAO1 1prf15/pM96, campycin expression strain, Gmr (15 µg/ml) This study
E. coli strains
BL21-CodonPlus (DE3)-RIL Contains a ColE1-compatible, pACYC-based plasmid containing extra copies of the argU, ileY,
and leuW tRNA genes and was used as a protein expression strain, Camr (50 µg/ml)
Agilent Technologies
InCj1 BL21-CodonPlus (DE3)-RIL/pAZInCj1, Innolysin Cj1 + chaperone co-expression strain, Kanr
(100 µg/ml), Camr (50 µg/ml)
This study
InCj2 BL21-CodonPlus (DE3)-RIL + pAZInCj2, Innolysin Cj2 + chaperone co-expression strain, Kanr
(100 µg/ml), Camr (50 µg/ml)
This study
InCj5 BL21-CodonPlus (DE3)-RIL + pAZInCj5, Innolysin Cj5 + chaperone co-expression strain, Kanr
(100 µg/ml), Camr (50 µg/ml)
This study
AZE1 BL21-CodonPlus (DE3)-RIL/pAZE1, T5 endolysin expression strain, Kanr (100 µg/ml), Camr
(50 µg/ml)
This study
AZE5 BL21-CodonPlus (DE3)-RIL/pAZE5, Salmonella phage Shivani peptidase expression strain,
Kanr (100 µg/ml), Camr (50 µg/ml)
This study
B195 BL21-CodonPlus (DE3)-RIL/CRYS3, C-terminal of H-fiber + chaperone co-expression strain,
Kanr (100 µg/ml), Camr (50 µg/ml)
This study
C. jejuni strains
NCTC11168 A preferred strain for studying phage-host interactions at the molecular level National collection of type cultures
NCTC11168 1kpsM1motA A capsular and non-motile flagellated NCTC11168 mutant Baldvinsson et al., 2014
TABLE 2 | Campylobacter jejuni strains used for testing antibacterial activity of Innolysins Cj.
C. jejuni strain ENA accession numbera MLSTb MLST CCc Origin
CAMSA2147 GCA_003095855 21 ST-21 Chicken
CAMSA2068 GCA_003095815 22 ST-22 Chicken
CAMSA2054 Not published 354 ST-354 Chicken
CAMSA2135 GCA_003095715 45 ST-45 Chicken
CAMSA2118 Not published 1,326 ST-45 Chicken
CAMSA2020 Not published 48 ST-48 Chicken
CAMSA2136 Not published 692 ST-692 Chicken
CAMSA2043 Not published 441 − Chicken
CAMSA2025 Not published 4,748 − Chicken
CAMSA2019 GCA_003095725 4,811 − Chicken
aAccession number based on European Nucleotide Archive (ENA).
bMultilocus sequence typing.
cMultilocus sequence typing clonal complexes.
determined using InterProScan (Jones et al., 2014) and HMMER
(Finn et al., 2011).
Plasmid Constructions
Construction of Plasmids for Campycin Expression
Multiple steps were conducted to construct plasmids pM63 and
pM96 composed of the coding sequence for the N-terminal
domain of R2-pyocin Prf15 fused with the coding sequence of
the C-terminal domain of the CAMSA2147 CJEI-like prophage
H-fiber (WP_002878910.1) with or without the downstream
gene for the putative chaperone (WP_002878909.1). Initially,
the coding sequence of the N-terminal domain of R2-pyocin
Prf15 (amino acids 1–164) was cloned into pUCPtac plasmid
(Williams et al., 2008) giving rise to pM50 (Table 3). Therefore,
P. aeruginosa PAO1 was used as a template for the amplification
of the fragment using R2N primers (Supplementary Table S1),
which add SalI and HindIII restriction sites at the ends of the
fragment. Then, the pUCPtac plasmid was linearized via inverse
PCR using specific primers (Supplementary Table S1) and
ligation was conducted with T4 DNA ligase. This plasmid (pM50)
(Table 3) was further used as backbone for creating the fusions
using In-Fusion R© cloning—Takara Bio. Therefore, the fragment
comprising the coding sequence of the C-terminus of the H-fiber
(amino acids 151–343) and the downstream chaperone gene
was amplified from CAMSA2147 (GCA_003095855) by specific
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TABLE 3 | Plasmids used or constructed.
Plasmid Construction Used for References
pUCPtac Modified pUCP30T (Gmr broad-host-range plasmid, Accession no:
U33752) containing laclq tac MCSa
Cloning vector Williams et al., 2008
pET-28a (+) N-His, N-Thrombin, C-His, Kanr (100 µg/ml) Expression vector Novagen
pM50 pUCPtac:N-terminus of prf15 of R2-pyocin lacking the binding domain,
Gmr (15 µg/ml)
Engineering R2-pyocins This study
pM63 pM50:C-terminus of H-fiber gene + chaperone gene of CAMSA2147
CJIE1, Gmr (15 µg/ml)
Campycin co-expression with chaperone This study
pM96 pM50:C-terminus of H-fiber gene of CAMSA2147 CJIE1, Gmr
(15 µg/ml)
Campycin expression This study
pAZE1 pET-28a (+):T5lys from phage T5, Kanr (100 µg/ml) T5 endolysin expression This study
pAZE5 pVTD: Salmonella phage Shivani peptidase gene, Kanr (100 µg/ml) Salmonella phage Shivani peptidase expression This study
pCRYS3 pET-28a (+):C-terminus of H-fiber gene + chaperone gene of
CAMSA2147 CJIE1, Kanr (100 µg/ml)
H-fiber expression This study
pAZInCj1 pET-28a (+):Innolysin Cj1 + chaperone gene of CAMSA2147 CJIE1,
Kanr (100 µg/ml)
Innolysin Cj1 expression This study
pAZInCj2 pET-28a (+):Innolysin Cj2 + chaperone gene of CAMSA2147 CJIE1,
Kanr (100 µg/ml)
Innolysin Cj2 expression This study
pAZInCj5 pVTD:Innolysion Cj5 + chaperone of CAMSA2147 CJIE1, Kanr
(100 µg/ml)
Innolysin Cj5 expression This study
aMCS, multiple cloning site.
primers that add overhangs identical to the distal ends of the
linearized pM50 (Supplementary Table S1). Inverse PCR was
conducted for the linearization of pM50. Recombination of the
fragment with the ends of the linearized pM50 was performed
according to the In-Fusion R© HD cloning kit user manual,
resulting in plasmids pM63 and pM96, respectively. Stellar
competent cells were used for transformation and transformants
were selected on LB agar plates in the presence of 15 µg/ml
gentamicin. P. aeruginosa PAO1 1prf15 were transformed with
the extracted plasmids as described previously (Choi et al., 2006).
Construction of Plasmids for Innolysin Cj Expression
Coding sequences for Innolysins Cj1 and Innolysin Cj2
were chemically synthesized by GeneCust (Luxembourg)
and cloned into pET-28a (+) using the NdeI and XhoI
restriction sites (Table 3). Plasmid pAZInCj1 expressing
Innolysin Cj1 was designed by fusing the coding sequence
of H-fiber protein of CJIE1-like prophage originating from
CAMSA2147 (WP_002878910.1) to the C-terminus of phage T5
endolysin coding sequence (YP_006868.1). A linker encoding
14 amino acids (Linker 2, Supplementary Table S2) was
used to join both coding sequences. The same configuration
was used for plasmid pAZInCj2 expressing Innolysin Cj2,
but instead of the whole H-fiber, the C-terminal part of
H-fiber coding sequence was used, excluding the N-terminal
DUF3751 domain. Both plasmids pAZInCj1 and pAZInCj2
also contain the flanking downstream gene of CAMSA2147, the
putative fiber chaperone (WP_002878909.1). In-Fusion R©
cloning was used to clone either the T5 endolysin or
the C-terminus (amino acids 151 to 343) of the H-fiber
(WP_002878910.1) along with the downstream chaperone
gene (WP_002878909.1) into peT28a (+), giving rise to the
control plasmids pAZE1 or pCRYS3, respectively (Table 3).
Amplification of these genes was performed with specific
primers (Supplementary Table S1) and using phage T5 (Leibniz
Institute DSMZ) or C. jejuni CAMSA2147 DNA as a template,
respectively. The vector pET28a (+) was linearized using NdeI
and XhoI restriction enzymes and insertion was performed
based on the In-Fusion R© HD cloning manual. Plasmids were
obtained after transformation of E. coli Stellar competent
cells and selection on LB agar with kanamycin (100 µg/ml).
Subsequently, all plasmids were used to transform E. coli
BL21-CodonPlus(DE3)-RIL (Agilent Technologies) by plating
on LB agar plates in the presence of kanamycin (100 µg/ml) and
chloramphenicol (50 µg/ml). All constructs were sequenced by
Sanger sequencing.
Expression of Campycins and
R2-Pyocins
Expression of campycin and native R2-pyocin, as a negative
control, was conducted as described previously (Williams et al.,
2008). Briefly, P. aeruginosa PAO1 expressing the native R2-
pyocin or campycin [i.e, a tail fiber deficient R2-pyocin derivative
(1prf15) substituted in trans with the H-fiber along with or
without the chaperone (PEG02 or PEG16)] were grown overnight
in TSB at 37◦C. The overnight cultures were 100-fold diluted in
G medium (Ikeda and Egami, 1969), which was supplemented
with 15 µg/ml gentamicin in the case of PEG02 and PEG16, and
were incubated at 37◦C until reaching an OD600 of 0.25. R2-
pyocins were induced by 3 µg/ml mitomycin, while isopropyl-
beta-D-thiogalactopyranoside (0.25 mM) was added to PEG02
and PEG16 for induction of the expression of the engineered
H-fiber in trans. Cultures were incubated for 2.5 h at the same
conditions, followed by treatment with DNase I (Invitrogen) at a
final concentration of 5 U/ml and further incubated for another
30 min at the same conditions. To remove cell debris, cultures
were centrifuged at 18,000 g at 4◦C for 1 h and the supernatants
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were harvested and treated with saturated ammonium sulfate
solution at a final concentration of 1.6 M, while stirring on
ice. Suspensions were incubated overnight at 4◦C with shaking
and the pellets containing the precipitated campycins/pyocins
were harvested after centrifugation at 4◦C and 18,000 g for 1 h.
The precipitates were resuspended in 1/10th of the start volume
with ice cold TN50 buffer (50 mM NaCl and 10 mM Tris-
HCl adjusted to pH 7.5) and buffer exchange was performed
with TN50 buffer by using Amicon Ultra-centrifugal Filter
Units with Ultracel-15 with 30 kDa membrane cutoff (Merck
Millipore). Concentration of campycins/pyocins was measured
with a Qubit 2.0 fluorometer and adjusted to 0.15 mg/ml
with TN50 buffer.
Determination of the Antibacterial
Activity of Campycins and R2-Pyocins
To assess the ability of campycins to kill Campylobacter, a
semi-quantitative assay was initially conducted by spotting 5 µl
onto Campylobacter bacterial lawns. Preparation of C. jejuni
CAMSA2147 lawns was performed as previously described
(Gencay et al., 2017). Briefly, bacterial cells were harvested from
the plate with calcium Brain- Heart Infusion Broth (cBHI)
and adjusted to an OD600 of 0.35. These suspensions were
further incubated for 4 h at 42◦C under microaerobic conditions
(6% CO2, 6% O2, 84.5% N2 and 3.5% H2) and 500 µl were
mixed with 5 ml of molten NZCYM overlay agar [NZCYM
broth (Sigma) with 0.6% agar (Sigma)]. The mixture was then
poured on NZCYM basal agar [with 1.2% agar (Sigma)] plates,
containing 10 µg/ml vancomycin [Sigma]. Plates were dried for
45 min in the flow hood and prepared campycins/pyocins were
spotted on top, followed by overnight incubation at 42◦C under
microaerobic conditions. The antibacterial activity was assessed
by the formation of a distinct clear zone as a result of cell killing
on the lawns. The native R2-pyocin or fiber mutant derivative
(1prf15) were also spotted onto Campylobacter bacterial lawns
as negative controls.
Antibacterial activity of campycin was also assessed by
measuring the bacterial log reduction in colony forming units
(cfu). C. jejuni was harvested from the plate with cBHI and
adjusted to an OD600 of 0.35 followed by tenfold dilution until
the final concentration reached 106 cfu/ml. Then, 9 ml of the
culture was mixed with either 1 ml of campycin at the final
concentration of 0.015 mg/ml or 1 ml of TN50 buffer, followed by
incubation for 3 h at 42◦C under microaerobic conditions. After
incubation, proper dilutions were made, and cells were plated on
BA plates. Incubation of plates was followed for 24 h at 42◦C
under microaerobic conditions and cfu/ml was calculated based
on biological triplicates.
Screening Innolysins Cj for Muralytic
Activity
To screen Innolysins Cj for muralytic activity, proteins were
expressed in E. coli BL21-CodonPlus-(DE3)-RIL cells, as
previously described (Zampara et al., 2020). Briefly, freshly
transformed colonies were re-suspended in 500 µl of auto-
induction medium [93% ZY medium, 0.05% 2M MgSO4,
2% 50 × 5052 (0.5% glycerol, 0.05% glucose, and 0.2% α-
lactose in 20 ml water), 5% 20 × NPS (50 mM Na2HPO4,
50 mM KH2PO4, and 25 mM (NH4)2SO4 to 50 mL of
water)]. Incubation was followed at 37◦C for 5 h at 900 rpm
and switched to 16◦C for 40 h at 900 rpm. Samples were
centrifuged (3,200 × g, 30 min, 4◦C) and cell pellets were
lysed by exposure to chloroform vapor for 2 h. Five hundred
microliters of 20 mM HEPES-NaOH (pH 7.4) with 1 U DNase
I was used for resuspension of cell lysates and samples were
incubated for 1 h at 30◦C. Cell suspensions were centrifuged
(3,200 × g for 30 min, at 4◦C) and the soluble fractions of
lysates present in the supernatants (cleared lysates) were used
for the muralytic assay as previously described (Lavigne et al.,
2004; Briers et al., 2014). Peptidoglycan of P. aeruginosa PAO1
was used as substrate, since it displays the same chemotype
(A1γ) as E. coli and C. jejuni (Schleifer and Kandler, 1972).
To permeabilize P. aeruginosa, pellets of exponentially growing
cells (OD600 = 0.6) were harvested by centrifugation (3,200 × g,
30 min, 4◦C) and resuspended in chloroform-saturated 0.05 M
Tris-HCl (pH 7.7) buffer. Gentle shaking for 45 min allowed
(outer) membrane permeabilization, followed by two washing
steps with phosphate-buffered saline (PBS, pH 7.4). The turbidity
of the outer membrane-permeabilized cells was adjusted to
OD600 = 1.5 and 270 µl was used as a substrate, while 30
µl of Innolysins Cj cleared lysates was applied on the top of
the substrate in triplicate. Cleared lysates of cells carrying the
empty vector pET-28a (+) or expressing phage T5 endolysin
were used as a negative and a positive control, respectively.
Turbidity was measured spectrophotometrically at 650 nm every
30 s for 1 h using a Microplate Reader 680 system (Bio-Rad)
and a standardized method was used to calculate the activities
(Briers et al., 2007).
Expression and Purification of Innolysins
Cj
To test the antibacterial activity, Innolysins Cj were expressed
by growing strains InCj1, InCj2, InCj5, and controls strains
AZE1 and B195 in 1 L auto-induction medium. Cultures were
incubated for 4 h at 37◦C and switched to 15◦C for 18 h
at 120 rpm. Cells were centrifuged (8,000 × g, 10 min, 4◦C)
and pellets were further resuspended in 10 ml of lysis buffer
(20 mM NaH2PO4-NaOH, 0.5 M NaCl, 50 mM imidazole, pH
7.4). Cells were lysed by sonication (Bandelin Sonopul HD 2070
homogenizer) with 10 bursts of 30 s (amplitude of 50%) and
30 s intervals. Cell lysates were filtered twice with 0.22 µm pore
size filters and protein purification was conducted by using His
GraviTrapTM gravity flow columns (GE Healthcare). The lysis
buffer was also used for the wash step, while elution step was
conducted by using 6 ml of 20 mM NaH2PO4-NaOH, 0.5 M
NaCl, 500 mM imidazole, pH 7.4. Amicon Ultra-15 Centrifugal
Filter Units with Ultracel-10 membrane cutoff (Merck Millipore)
were used for exchange of the elution buffer with 20 mM HEPES-
NaOH (pH 7.4). Sodium dodecyl sulfate- polyacrylamide gel
electrophoresis (SDS-PAGE) was used to determine purity of
samples (Supplementary Figure S1) and protein concentration
was measured with a Qubit 2.0 fluorometer.
Frontiers in Microbiology | www.frontiersin.org 5 February 2021 | Volume 12 | Article 619028
fmicb-12-619028 January 25, 2021 Time: 16:18 # 6
Zampara et al. Innolysins Against Campylobacter jejuni
In vitro Antibacterial Activity of Purified
Innolysins Cj
The killing efficiency of Innolysins Cj was tested on different
Campylobacter strains (Table 2). C. jejuni strains were cultured
on Mueller Hinton (MH) agar plates for 24 h at 42◦C under
microaerobic conditions (6% CO2, 6% O2, 84.5% N2, and 3.5%
H2). MH broth was used to harvest and to exponentially grow
the cells until they reach an optical density OD600 of 0.25.
The cell suspensions were further diluted with MH down to
a concentration of 105 cfu/ml. 100 µl of the diluted samples
were mixed with either 100 µl of purified Innolysin at the final
concentration of 1 mg/ml or 100 µl of 20 mM HEPES-NaOH (pH
7.4) instead, for negative controls. After incubation for 45 min at
20◦C, proper dilutions were made and plated on BA agar plates.
Overnight incubation was followed at 42◦C under microaerobic
conditions and cfu were counted. Cell concentrations (cfu/ml)
were calculated and cell reductions were estimated as a difference
of the average logarithmic cell concentrations of the cultures
treated with Innolysin compared to the negative control. The
experiment was conducted in biological triplicate.
Preparation of Innolysin Cj Library
To prepare the Innolysin Cj library, we used the previously
described VersaTile technique (Gerstmans et al., 2020). Initially, a
semi-random combinatorial library with each variant composed
of four tiles was constructed: one H-fiber tile at position
1, seven linker tiles at position 2, 25 enzymatic activity
domain (EAD) tiles at position 3 and one hexahis-tag tile at
position 4. The library has a complexity of 175 (= 1∗7∗25∗1)
possible variants. The EAD and linker tiles were previously
constructed (Supplementary Tables S2, S3) and were readily
available as plasmid stocks (Gerstmans et al., 2020). The
H-fiber tile (RBP8) was created according to the protocol
for tile preparation described in Gerstmans et al. (2020).
Briefly, the RBP coding sequence was first amplified using
tailed primers (Supplementary Table S1) and purified using
gel extraction (GeneJet Gel Extraction Kit, Thermo Fisher
scientific). Subsequently, the fragment was cloned in the entry
vector (pVTE) using 2U T4 DNA ligase (Thermo Fisher
Scientific), 5U sapI (Thermo Fisher Scientific), 26 nM pVTE,
46 nM fragment and ligase buffer (Thermo Fisher Scientific).
5 µL of the resulting reaction mixture was used to transform
chemically competent E. coli TOP10 cells, followed by selective
plating on LB agar supplemented with 5% (w/v) sucrose
and ampicillin (100 µg/mL). The sequence of each tile was
verified by Sanger sequencing (LGC genomics). Subsequently,
the VersaTile assembly mixture was made taking 1 µL of 46
nM entry vector containing the corresponding tile or a mixture
of tiles for each position, 26 nM pVTD, 2U T4 DNA ligase
(Thermo Fisher Scientific), 5U BsaI (Thermo Fisher Scientific),
and ligase buffer (Thermo Fisher Scientific). This mixture was
incubated for 50 cycles alternating between 37◦C (5 min) and
16◦C (5 min), followed by heat inactivation at 50◦C (5 min)
and 80◦C (5 min). The resulting reaction mixture was used
to transform competent E. coli BL21(DE3)-RIL cells and the
transformed cells were subsequently plated on LB 1.5% agar
plates supplemented with kanamycin (50 µg/mL) and 5% (w/v)
sucrose. VersaTile technique was also used for cloning the gene
encoding Salmonella phage Shivani peptidase (YP_009194685)
into pVTD vector (Supplementary Figure S2), using the tile
carrying the responsible gene at position 1 and the tile carrying
the hexahis-tag at position 2. The resulting reaction mixture
was used to transform competent E. coli BL21(DE3)-RIL as
mentioned above.
Screening of Innolysin Cj Library for
Growth Inhibition
After transformation, 96 clones were randomly selected and
screened for growth inhibition. The library variants were
expressed using auto-induction medium in a 96 deep-well plate
and the cleared lysates were harvested as described in the
screening of Innolysins Cj for muralytic activity. The ability
of the Innolysins Cj to inhibit the cell growth was tested on
CAMSA2147 similar to previous work (Zampara et al., 2020).
Briefly, CAMSA2147 was cultured on MH agar plates for 24 h
at 42◦C under microaerobic conditions (6% CO2, 6% O2, 84.5%
N2, and 3.5% H2) and cells were harvested with 2×MH broth
and adjusted to 0.05 optical density OD600. 50 µl of the diluted
cultures were mixed with 50 µl of the soluble lysate fraction
of cells expressing each Innolysin. CAMSA2147 mixed with
20 mM HEPES-NaOH (pH 7.4) buffer was used as negative
control. Mixed samples were incubated for 24 h at 42◦C under
microaerobic conditions (6% CO2, 6% O2, 84.5% N2, and 3.5%
H2). Lack of growth was assessed as reduced turbidity of cultures
compared to the negative control by measuring the optical
density spectrophotometrically at 600 nm. This high-throughput
screening was performed with technical triplicates.
In situ Antibacterial Activity of Innolysins
Cj
The antibacterial activity of either Innolysin Cj1 or Innolysin
Cj5 was tested against CAMSA2147 on artificially contaminated
chicken skin supplied from a Danish slaughterhouse. Frozen
chicken skins were defrosted on the day of the experiments
and were aseptically cut into 3×4 cm (12 cm2) pieces. Each
of the chicken pieces was treated with 20 µl of the strain
containing in total 104 cfu that were evenly spread over the
surface and immediately thereafter exposed to 50 µl of each
Innolysin (200 µg) or 50 µl of 20 mM HEPES-NaOH (pH 7.4)
as a negative control. Samples were exposed for 45 min under
modified packaging conditions (30% CO2, 70% N2) at 5◦C. After
exposure, skin pieces were put in plastic bags and weighted. Cells
were harvested by using 10 ml of 20 mM HEPES-NaOH (pH
7.4) buffer and by shaking the samples in the stomacher for
1 min. Harvested solutions were serially tenfold diluted in 20 mM
HEPES-NaOH (pH 7.4) and plated on Campy Rapid plates that
are selective for Campylobacter. Incubation of plates was followed
for 48 h under microaerobic conditions at 42◦C. C. jejuni colonies
were counted and compared with the number of recoverable
bacteria of the control samples. Average log reduction of bacterial
cells per gr was estimated based on biological triplicate.
Frontiers in Microbiology | www.frontiersin.org 6 February 2021 | Volume 12 | Article 619028
fmicb-12-619028 January 25, 2021 Time: 16:18 # 7
Zampara et al. Innolysins Against Campylobacter jejuni
Statistical Analysis
Statistical analysis of the results was conducted by using
GraphPad Prism 7 software (Version 7.0d). The Paired-Samples
t-test with 95% confidence interval percentage was used to test
the significance of logarithmic bacterial reduction of cells treated
with either campycin or Innolysins Cj compared to the negative
controls (cells treated with TN50 buffer or 20 mM HEPES-NaOH
(pH 7.4), respectively). To test whether the muralytic activities
of cleared lysates of cells expressing Innolysins were significant
compared to the negative control [muralytic activity of cleared
lysate of cells carrying empty vector, pET28a (+)], the Unpaired-
Samples t-test was used with 95% confidence interval based on
biological triplicates.
RESULTS
Identification of Campylobacter Phage
RBP for Construction of Innolysins Cj
In order to construct Innolysins against Campylobacter, we first
aimed to identify the RBP of the CJIE1-like prophage in C. jejuni
CAMSA2147. Since mutations often accumulate in RBPs due to
adaptations to variations in host receptors (Nobrega et al., 2018),
the observed variability of the H-fiber of CJIE1-like prophages
(Clark and Ng, 2008) may indicate that it functions as the RBP
of the prophage. C. jejuni CAMSA2147 also carries an CJIE1-
like prophage encoding a H-fiber. Bioinformatic analysis showed
that the N-terminus of this H-fiber harbors a DUF3751 domain
analogous to the N-terminal domains of the coliphage P2 protein
H and the Prf tail fiber of R2-pyocin in P. aeruginosa PAO1
(Figure 1A). This tail fiber domain functions as an anchor,
allowing the tail fiber to attach to the R2-pyocin (Williams et al.,
2008). Moreover, the gene downstream of the H-fiber gene has
a DUF4376 domain similar to the U gene located downstream
of the tail fiber gene of phage Mu. The U gene encodes a
chaperone that is required for the functionality of the phage
Mu RBP (Haggard-Ljungquist et al., 1992; North et al., 2019).
Therefore, our bioinformatic analysis showed that the H-fiber
shares common features with RBPs of other phages, suggesting
that it may function as an RBP for the CJIE1-like prophages.
The Tail Fiber Protein H of
Campylobacter CJIE1-Like Prophage
Functions as an RBP
To demonstrate binding of the H-fiber to Campylobacter, we
exploited the principle of tail fiber switching of the R2-pyocin.
The R2-pyocin is a bacteriocin morphologically similar to the
tail complex of simple myoviruses such as coliphage P2 or Mu
(Nakayama et al., 2000; Leiman and Shneider, 2012). Its tail fibers
bind to the bacterial receptors, followed by contraction of the
tail and pore formation in the cell membrane, thus dissipating
the bacterial membrane potential leading to cell lysis (Michel-
Briand and Baysse, 2002; Ge et al., 2020). Thus, to show that
the H-fiber functions as an RBP, we engineered the R2-pyocin by
exchanging the receptor binding domain of the tail fiber of native
R2-pyocin with the C-terminus of the H-fiber gene of CJIE1-like
prophage from C. jejuni CAMSA2147 (Figure 1B). We named
this engineered pyocin campycin, because the presence of the
C-terminus of the H-fiber should redirect the bactericidal effect to
Campylobacter. We further co-expressed the campycin with the
putative chaperone in case it may be needed for the functionality
of the H-fiber (Figure 1B). All constructs were transformed to
a P. aeruginosa PAO1 derivative carrying all other components
of the R2-pyocin but lacking the tail fiber due to a deletion of
gene prf15. The substituting tail fiber was thus expressed in trans,
allowing formation of the campycins.
We expressed and spotted campycin on CAMSA2147 bacterial
lawns. The appearance of lysis zones on bacterial lawns indicate
the ability of campycin to bind and kill the cells (Table 4).
Interestingly, the campycin only caused lysis of CAMSA2147
bacterial lawns when it was co-expressed with the putative
chaperone. In contrast, the campycin alone, the native R2-pyocin
or the native R2-pyocin lacking the tail fiber (Prf15) were not
able to lyse CAMSA2147. These results prove that the H-fiber of
the CJIE1-like prophage is able to bind to C. jejuni, suggesting
that it functions as an RBP and that the downstream putative
chaperone is required for its functionality. To further confirm
that the H-fiber of campycin binds to and kills C. jejuni, reduction
of CAMSA2147 colony forming units (cfu) was determined
after treatment with campycin expressed with or without the
chaperone. Indeed, an average 1.88 log reduction of cells was
shown when CAMSA2147 was treated with the campycin co-
expressed with the chaperone (Figure 2), whereas the campycin
alone did not lead to significant reduction of cells compared to
the control (cells treated with TN50 buffer). Currently described
receptors for lytic Campylobacter phages include the capsule or
the flagellum (Sørensen et al., 2015). To investigate whether any
of these structures functions as the receptor for the H-fiber of
CJIE1-like prophage, native R2-pyocin and campycin were tested
for cell lysis on bacterial lawns of C. jejuni NCTC11168 lacking
both the capsule and flagella (NCTC11168 1kpsM1motA) and
the wildtype strain as a control. A clear lysis zone was observed
on NCTC11168 1kpsM1motA similar to the wildtype (Table 4),
indicating that the campycin recognizes a receptor different
from the capsule and flagella. Overall, the H-fiber derived from
the CJIE1-like prophage of CAMSA2147 functions as a novel
Campylobacter phage RBP that requires the downstream located
chaperone to be functional.
Campylobacter Targeting Innolysins
Remain Muralytic Active
We utilized the newly discovered RBP to target Innolysins
against C. jejuni (Innolysins Cj). Therefore, we fused the H-fiber
to phage T5 endolysin and anticipated that binding of the
H-fiber to C. jejuni allows the fused endolysin to overcome
the outer membrane barrier and to exert antibacterial activity.
Innolyins Cj were designed with the same configuration as our
previously most efficient Innolysin targeting E. coli (InEc21).
InEc21 was composed of an N-terminal endolysin and a
C-terminal RBP, fused with a flexible linker (Zampara et al.,
2020). Thus, Innolysins Cj1 was composed of the T5 endolysin
in the N-terminus fused by a long flexible linker with the
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FIGURE 1 | Domains of the tail fiber region of CJIE1-like prophages and construction of campycins. (A) Domains of H-fiber C. jejuni prophage CJIE1-like in
comparison to prophage Mu and R2-pyocin. The H-fiber of CJIE1-like prophages harbors an N-terminal DUF3751 domain similar to the P. aeruginosa PAO1
R2-pyocin tail fiber encoded by prf15 (Williams et al., 2008). The gene downstream of the H-fiber gene is predicted to encode a DUF4376 domain as found in the U
gene that functions as a chaperone for the Mu phage tail fiber (Haggard-Ljungquist et al., 1992). (B) For construction of campycin, the DUF3751 domain encoded by
P. aeruginosa PAO1 R2-pyocin was fused with the C-terminus of the CAMSA2147 H-fiber.
TABLE 4 | Formation of clear lysis zones on lawns of different Campylobacter strains.
Bacterial strains Native R2-pyocin R2-pyocin lacking fibera Campycin Campycin + chaperone
C. jejuni CAMSA2147 − − − +
C. jejuni NCTC11168 − − − +
C. jejuni NCTC11168 1kpsM1motAb − − − +
aP. aeruginosa PAO1 R2-pyocin lacking the tail fiber due to deletion of responsible gene prf15.
bMutant of NCTC11168 lacking both the capsule and a motile flagella.
H-fiber in the C-terminus. The same configuration was used
for Innolysin Cj2, but only using the C-terminal part of the
H-fiber without the DUF3751 domain as an RBP component
(Figure 3). Furthermore, both Innolysins Cj were co-expressed
with the chaperone of CAMSA2147 CJIE1-like prophage to
ensure functionality of the H-fiber.
To verify that the T5 endolysin remains enzymatically active
within the hybrid proteins, we tested the ability of Innolysins
Cj1 and Cj2 to degrade peptidoglycan. The enzymatic activity of
cleared lysates of expressed Innolysins Cj was determined using
outer membrane permeabilized P. aeruginosa cells, which serve as
a reference substrate for peptidoglycan degrading activity (Briers
et al., 2007). Innolysin Cj1 and Innolysin Cj2 displayed muralytic
activities of 2,360 and 1,229 U/ml, respectively, while T5
endolysin alone has a muralytic activity of 2,807 U/ml (Figure 4).
Yet, precise comparisons are not possible because cleared lysates
were used, thus the observed activities are dependent on both
product yield and specific activity. Overall, our results indicate
that both Innolysins are able to exert enzymatic activity and
degrade the peptidoglycan.
Innolysins Cj Exert Antibacterial Activity
Against Various Campylobacter Strains
To evaluate whether Innolysins Cj1 and Cj2 exert antibacterial
activity against Campylobacter, we treated Campylobacter
CAMSA2147 with 1 mg/ml of purified Innolysin Cj1 or Innolysin
Cj2 for 45 min at 20◦C. Innolysins Cj1 led to 1.30 ± 0.21 log
reduction of cell counts, in contrast to Innolysin Cj2 that did
not lead to significant log reduction (0.10 ± 0.21) (Figure 5).
Furthermore, no significant log reduction was detected when
cells were treated with 1 mg/ml of either the H-fiber (0.05 ± 0.03)
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FIGURE 2 | Antibacterial activity of campycin against Campylobacter
CAMSA2147. Campycin was expressed with or without chaperone and mixed
with CAMSA2147. TN50 buffer was used instead of campycins as a negative
control. Samples were incubated for 3 h in microaerobic conditions at 37◦C.
Colony forming units per milliliter (cfu/ml) were counted. Experiments were
performed in triplicates. Error bars represent the standard deviations of the
mean. *Significant reduction at P < 0.05.
or the T5 endolysin (0.16 ± 0.15) alone. These results indicate
that the whole H-fiber may be a more potent RBP component
compared to the C-terminal part of H-fiber. To determine
the antibacterial spectrum of Innolysins Cj, the antibacterial
activity of each Innolysin was tested against nine Campylobacter
strains belonging to distinct multilocus sequence types (MLST)
(Djordjevic et al., 2007; Table 2). All strains were sensitive to
Innolysin Cj1, leading to a maximum of 1.33 ± 0.19 log reduction
in cell numbers of CAMSA2019. In contrast, Innolysin Cj2 only
exerted antibacterial activity against two strains (CAMSA2068
and CAMSA2118), reaching to 0.90 ± 0.30 log reduction of
CAMSA2068 cells (Figure 5). Thus, it appears that Innolysin
Cj1 is a better antibacterial candidate with a wider antibacterial
spectrum compared to Innolysins Cj2. Overall, we showed that
the H-fiber can be used as an RBP component of Innolysins to
specifically kill diverse Campylobacter strains.
Construction and Screening of an
Innolysin Cj Library Yields an Additional
Antibacterial Candidate
To possibly enhance the antibacterial activity of Innolysins
Cj, we designed a library of novel Innolysins Cj by changing
the configuration and using other EADs and linkers. For the
construction of the library, we used the VersaTile technique
(Gerstmans et al., 2020), which is a dedicated method for the
combinatorial assembly of modular proteins. Specifically, the
library variants were designed as such that the whole H-fiber
is located now in the N-terminus and fused by one of seven
possible linkers to one of 25 different EADs of phage lytic
enzymes in the C-terminus. All variants also have a C-terminal
hexahis-tag for purification purposes. The library has thus a final
complexity of 175 possible variants. To identify the Innolysin
Cj candidate with improved antibacterial activity, we used a
high-throughput screening method based on bacterial growth
inhibition. Specifically, 96 variants were randomly picked after
transformation and screened by mixing CAMSA2147 cells with
cleared cell lysates expressing an Innolysins Cj variant, followed
by monitoring of the optical density of the cultures during 24 h.
CAMSA2147 cells mixed with 20 mM HEPES-NaOH (pH 7.4)
buffer served as a negative control, and led to an OD600 of
0.77 ± 0.04. The highest growth inhibitory effect was observed
for Innolysin Cj5 that reduced growth to an OD600 of 0.33 ± 0.05.
Sequencing revealed that Innolysin Cj5 was composed of an
EAD with a putative endopeptidase activity from Salmonella
phage Shivani (Supplementary Table S3) fused with a 13 amino-
acid long rigid linker (LINK7, Supplementary Table S2) to the
N-terminal H-fiber. To determine the antibacterial activity of
Innolysin Cj5, we further purified Innolysin Cj5 and tested the
antibacterial activity against CAMSA2147. Exposure to Innolysin
Cj5 led to 1.16 ± 0.04 log reduction of cells, which was in
a similar range as Innolysin Cj1. In contrast, application of
Salmonella phage Shivani endolysin alone did not significantly
reduce CAMSA2147 cells under the same conditions (0.28 ± 0.02
log reduction). Thus, changing the configuration of Innolysins Cj
did not enhance the antibacterial activity, but the configuration
is flexible as for both opposite configurations more than 1 log
reduction of Campylobacter cells was identified.
Antibacterial Activity of Innolysin Cj1 and
Cj5 on Chicken Skin
To test whether Innolysins Cj could kill Campylobacter present
on food products, we tested the antibacterial activity of either
Innolysin Cj1 or Innolysin Cj5 against CAMSA2147 in situ.
Chicken skin was inoculated with CAMSA2147 (104 CFU) and
treated immediately afterward with 200 µg of either Innolysin Cj1
or Innolysin Cj5. For negative controls, 20 mM HEPES-NaOH
(pH 7.4) buffer was used instead. After 45 min of exposure of
the samples under modified packaging conditions (30% CO2,
70% N2) at 5◦C, the log reduction of cells per gr chicken skin
was assessed. A 1.63 ± 0.46 and 1.18 ± 0.10 log reduction was
shown when CAMSA2147 was treated with either Innolysin Cj1
or Innolysin Cj5, respectively, compared to the negative controls.
These results are in accordance with our in vitro experiments
and show that Innolysins Cj have the potential to be used as
antibacterial agents against Campylobacter on food.
DISCUSSION
Phage-derived RBPs are broadly and elegantly being exploited
for designing novel antibacterials due to the specificity that they
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FIGURE 3 | Construction of Innolysins Cj. Innolysin Cj1 was constructed by fusing the C-terminus of phage T5 endolysin to the tail fiber protein H of Campylobacter
CAMSA2147 CJIE1-like prophage. These two domains were fused by using a linker in between composed of 14 amino acids (GAGAGAGAGAGAGA). The same
configuration was used for Innolysin Cj2 but instead of the whole H-fiber, the C-terminal part of the H-fiber was used, excluding the N-terminal DUF3751 domain.
FIGURE 4 | Muralytic activity of Innolysins Cj. Enzymatic activities of Innolysins
Cj1 and Cj2 were tested on outer membrane-permeabilized P. aeruginosa
substrate in triplicate. Cleared lysates of cells expressing Innolysins Cj were
used for the assay. Cleared lysates of cells expressing either the phage T5
endolysin (T5 Lys) or carrying the empty vector pET-28a (+) were used as
positive and negative controls, respectively. Enzymatic activities were depicted
as units per milliliter (U/ml) without normalization for product expression yield.
Error bars represent the standard deviations of the mean. *Significant
muralytic activity at P < 0.05.
provide when they bind to the receptors on the bacterial surface
(Dams et al., 2019). For example, we recently used a phage RBP
to enable endolysin to overcome the outer membrane barrier
and to kill Gram-negative bacteria (Zampara et al., 2020). We
constructed Innolysins Ec composed of an EAD fused with the
phage T5 RBP, Pb5 to specifically kill E. coli. Screening of a
large library of Innolysins Ec for antibacterial activity allowed us
to select Innolysin Ec21, displaying bactericidal activity against
both laboratory and antibiotic-resistant E. coli strains (Zampara
et al., 2020). Here, we expanded upon the Innolysin concept by
developing Innolysins to kill C. jejuni, which is responsible for
more than 90% of cases of campylobacteriosis (Sheppard et al.,
2009; Kaakoush et al., 2015).
Since no C. jejuni phage RBPs have been identified so far,
we used bioinformatic analysis to predict that the H-fiber
protein encoded by CJIE1-like prophages functions as an
RBP. To demonstrate the function, we engineered R2-type
pyocin to carry the C-terminus of the H-fiber derived from
CAMSA2147 CJIE1-like prophage and showed that it is able
to kill C. jejuni strains. Interestingly, the H-fiber requires co-
expression of the downstream gene to function as an RBP.
The C-terminus of the coding sequence of this gene contains
a DUF4376 domain that displays homology to the C-terminus
of the E. coli Mu phage tail fiber assembly (Tfa) protein
(TfaMu). Tfa proteins are composed of a variable N-terminal
domain that binds to the C-terminal region of the tail
fiber and a conserved C-terminus (DUF4376) that mediates
assembly and multimerization of the fiber (North et al., 2019).
Similarly, the C-terminus of the protein identified downstream
of the H-fiber of CJIE1-like prophages may be involved in
oligomerization and assembly of the fibers. Furthermore, TfaMu
is an intermolecular chaperone that remains bound to the
fiber of phage Mu, however, the exact function remains to be
clarified (Haggard-Ljungquist et al., 1992; North et al., 2019).
In other phages like E. coli phage T2 and T6, the downstream
genes encode proteins that bind to the tail fibers and regulate
recognition of bacterial receptors (Riede et al., 1987). Therefore,
the downstream gene may influence the functionality of the
H-fiber of CJIE1-like prophage by tail fiber oligomerization
and assembly and/or recognition of the receptor. While lytic
C. jejuni phages have been shown to recognize either flagella
or capsular polysaccharides as receptors (Sørensen et al., 2015),
our data suggests that the H-fiber and thus CJIE1-like prophages
recognize a previously not described receptor. Overall, we
provide novel insight of phage-host interaction of CJIE1-like
prophages by identifying the RBP and we provide a new
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FIGURE 5 | Antibacterial spectrum of Innolysins Cj against C. jejuni strains. The bacterial log reduction of different C. jejuni strains was determined after application of
1 mg/ml purified Innolysin Cj1 or Innolysin Cj2 and exposed for 45 min at 20◦C. Average logarithmic reductions of treated cells were measured compared to the cells
treated with 20 mM HEPES-NaOH (pH 7.4) (Innolysins buffer solution). The C. jejuni strains were derived from the Statens Serum Institute (SSI) collection isolated
from poultry and pork in Denmark, showing different multilocus sequence typing (MLST) and different MLST clonal complexes (CC) (Table 2). The average logarithmic
reduction was calculated based on three independent experiments. Error bars represent the standard deviations of the mean. *Significant reduction at P < 0.05.
component for redirecting the antibacterial activity of Innolysins
to Campylobacter.
By using the H-fiber derived from CAMSA2147 as the
RBP component, we constructed two Innolysins Cj to kill
Campylobacter jejuni, by fusing it to the C-terminus of T5
endolysin with a flexible linker in between. Innolysin Cj1
composed of the whole H-fiber as RBP component killed all
10 Campylobacter strains tested, reaching to 1.30 ± 0.21 log
reduction of CAMSA2147 cells. In contrast, Innolysin Cj2
composed of the C-terminal part of the H-fiber could only
significantly kill two out of the 10 strains. We previously
suggested that the mode of Innolysins action relies on the binding
of Innolysins RBP component to the bacterial receptors. This
binding brings the fused endolysin to close proximity to the cell
surface, where the positive charge of the endolysin may interfere
with the outer membrane stabilizing cations (Zampara et al.,
2020). As a result, the outer membrane integrity is impaired
(Smoluch et al., 2016), allowing the endolysin to access and
thereby degrade the peptidoglycan. Thus, we expect that the
whole H-fiber may bind with higher affinity to the receptor
compared to the C-terminal part of H-fiber, resulting to a broader
antibacterial activity of Innolysin Cj1 compared to Innolysin
Cj2. Further engineering allowed us to construct a library of
Innolysins with a different configuration compared to Innolysin
Cj1 and Innolysin Cj2. Based on a high-throughput screening
for growth inhibition, we selected Innolysin Cj5 as a potent
antibacterial candidate, leading to 1.16 ± 0.04 log reduction
of CAMSA2147 cells in vitro. Although we did not identify
an Innolysin with increased antibacterial activity compared to
Innolysin Cj1, the platform offers opportunities for developing
additional Innolysins Cj as antibacterial candidates. This is a
novel concept for developing agents to control Campylobacter by
exploiting phage RBPs and muralytic enzymes.
Chicken skin may be contaminated with high levels of
C. jejuni during multiple stages of processing (Hansson et al.,
2015; Biesta-Peters et al., 2019; Iannetti et al., 2020). Therefore, we
used chicken skin as a food model system to test the antibacterial
activity of Innolysins Cj against C. jejuni. Application of either
Innolysin Cj1 or Innolysin Cj5 under food storage conditions
led to 1.63 ± 0.46 and 1.18 ± 0.10 log reduction per gram
chicken skin, respectively. Although the killing efficiency of
Innolysin Cj1 by 1.63 ± 0.46 log reduction appears moderate,
it has been predicted that campylobacteriosis cases derived from
consumption of contaminated chicken meals could be decreased
30 times by a 2 log reduction of Campylobacter numbers on the
chicken carcasses (Rosenquist et al., 2003). Thus, the antibacterial
activity of Innolysins Cj could have a substantial impact on food
safety and thus the number of human disease cases. Application
of phage cocktails in situ against C. jejuni NCTC12662 under
similar set up on chicken skin did not exceed 1 log reduction
(Zampara et al., 2017). Therefore, Innolysins appear more
efficient antibacterial agents compared to such phage application.
Furthermore, Innolysin Cj approach offers advantages compared
to phage application, because phage resistance can emerge due
to Campylobacter intracellular adaptive mechanisms, such as
intragenomic rearrangement between Mu-like prophages and
phase-variable restriction modification systems (Scott et al.,
2007; Anjum et al., 2016). In the case of Innolysins, bacterial
resistance is most likely limited to mutations of the receptor for
Innolysin binding. This could subsequently result in a reduced
virulence, depending on the nature of the bacterial receptor. Since
Innolysin Cj1 is able to kill a diverse spectrum of C. jejuni, the
H-fiber appears to bind to a conserved receptor. Furthermore, a
combined application of Innolysins targeting different receptors
on Campylobacter at the same time may reduce the risk of
bacterial resistance, as mutation of multiple receptors would be
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required instead of one. Here we showed that engineering of R2-
pyocins of P. aeruginosa is a useful platform for discovery of novel
RBPs to be used for development of novel Innolysins Cj. Overall,
we used a novel RBP originating from a prophage to develop
Innolysins Cj and expand the reservoir of potent antibacterials
against Campylobacter.
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